The standout valuation metric is the PEG of 0.1x, which implies that the market is pricing in exceptionally high earnings acceleration; if Microvast can sustain its projected ~86% growth rate, the stock could quickly reprice to a more typical PEG range (≈1.0), delivering significant upside.
A key valuation risk is the reliance on near‑term earnings acceleration; if actual growth falls short of the implied ~86% rate and settles nearer to historical averages (~30-40%), the forward P/E could compress back toward 12x, eroding the current discount and potentially triggering a price correction of 15-20%.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 2.5% (10Y CAGR) | Analyst Rev × 13.1% margin |
| PV of FCF | $215.3M | $386.9M |
| Terminal Value (PV) | $374.8M | $792.8M |
| Enterprise Value | $590.1M | $1.18B |
| Equity Value | $509.2M | $1.10B |
| Implied Stock Price | $17.31 | $37.36 |
| Upside/Downside | +1163.7% | +2627.1% |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 10.2% | $20 | $21 | $23 | $24 | $25 |
| 11.2% | $18 | $19 | $20 | $21 | $22 |
| 12.2% | $16 | $17 | $17 | $18 | $19 |
| 13.2% | $14 | $15 | $16 | $16 | $17 |
| 14.2% | $13 | $14 | $14 | $14 | $15 |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 10.2% | $44 | $46 | $49 | $51 | $55 |
| 11.2% | $39 | $41 | $42 | $44 | $47 |
| 12.2% | $35 | $36 | $38 | $39 | $41 |
| 13.2% | $31 | $32 | $34 | $35 | $36 |
| 14.2% | $29 | $29 | $30 | $31 | $32 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $4.02 | +193.4% | Peer median P/E (25.1x) × Forward EPS ($0.16) |
| P/B (Peer) | $2.35 | +71.6% | Peer median P/B (3.80x) × Book Value per Share |
| EV/EBITDA (Peer) | $1.90 | +38.4% | Peer median EV/EBITDA (9.5x) × EBITDA - Net Debt |
| P/S (Peer) | $1.04 | -23.9% | Peer median P/S (1.62x) × Revenue per Share |
| DCF | $17.31 | +1163.7% | Revenue × FCF Margin projection |
| Analyst Target | $4.80 | +250.4% | Consensus of 1 analysts |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net